EMAIL THIS PAGE TO A FRIEND

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer.


PMID 25861022

Abstract

The aim of this study was to explore the expression and clinical significance of miR-494 and PTEN (phosphatase and tensin homologue deleted on chromosome ten) in non-small cell lung cancer (NSCLC). Immunohistochemistry for PTEN and in situ hybridization (ISH) for miR-494 were performed in 92 NSCLC tissues and 10 normal lung tissues to detect their expression, and correlation between their expression with clinical characteristics and prognosis was analyzed. The expression of miR-494 was significantly higher in NSCLC than in normal lung tissues (P = 0.004). The positive expression of PTEN protein in the lung carcinoma tissues was significantly lower than that in the normal lung tissues (P = 0.013), while the level of miR-494 expression was negatively correlated with PTEN expression (r = -0.577, P < 0.01). The high positive rate of miR-494 was positively correlated with pathological TNM (p-TNM) staging and lymph node metastasis. The expression of miR-494 was negatively correlated with grade of differentiation. However, the expression of PTEN was positively correlated with grade of differentiation. Patients with over-expression of miR-494 had a shorter overall survival (OS), while the negative group of PTEN was correlated with poor OS. MiR-494 over-expression and low PTEN expression are closely related to tumor p-TNM staging and lymph node metastasis, differentiation, and OS. Combined detection of PTEN and miR-494 can aid in determining malignancy degree and the prognosis of patients with NSCLC. MiR-494 may be served as a novel prognostic factor and may lead to new treatment strategies for NSCLC.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4300337
Anti-PTEN (Ab-370) antibody produced in rabbit, affinity isolated antibody
SAB4300336
Anti-PTEN (Ab-380/382/383) antibody produced in rabbit, affinity isolated antibody
SAB2501614 Anti-PTEN antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1406331
Anti-PTEN antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
P7482
Anti-PTEN antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB3500337
Anti-PTEN antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4502473
Anti-PTEN, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4502474
Anti-PTEN, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4502475
Anti-PTEN, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4502476
Anti-PTEN, C-Terminal antibody produced in rabbit, affinity isolated antibody
WH0005728M1
Monoclonal Anti-PTEN antibody produced in mouse, clone 2G9, purified immunoglobulin, buffered aqueous solution
P3487
Monoclonal Anti-PTEN antibody produced in mouse, ~1 mg/mL, purified immunoglobulin, clone PTN-18, buffered aqueous solution
SAB1404272
Monoclonal Anti-PTEN antibody produced in mouse, clone 3E7, purified immunoglobulin, buffered aqueous solution
SAB4100580
Monoclonal Anti-PTEN antibody produced in mouse, clone PTEN-A552, culture supernatant
PLA0133
Rabbit anti-PTEN Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.